SCHEMBL2733172

SCHEMBL2733172

C=CCC[C@@H](N)c1ccccc1-c1c(C(=O)O)n(S(=O)(=O)c2ccccc2)c2ccccc12

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACLY P53396 1/20 0.37
AGTR1 P30556 3/20 0.35
HTR6 P50406 6/20 0.33
RECQL P46063 1/20 0.33
FABP3 P05413 1/20 0.32
FABP4 P15090 1/20 0.32
FABP5 Q01469 1/20 0.32
PSEN1 P49768 3/20 0.32
PSEN2 P49810 3/20 0.32
APH1B Q8WW43 3/20 0.32
NCSTN Q92542 3/20 0.32
APH1A Q96BI3 3/20 0.32
PSENEN Q9NZ42 3/20 0.32
LMNA P02545 2/20 0.31
PSMD14 O00487 1/20 0.31
SRC P12931 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
POLB P06746 1/20 0.31
THRB P10828 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2732153 0.85 ACLY (0.40) ACLYAGTR1HTR6RECQLFABP3
SCHEMBL2724860 0.84 ACLY (0.39) ACLYAGTR1HTR6RECQLFABP3
SCHEMBL2726604 0.81 ACLY (0.41) ACLYAGTR1HTR6RECQLFABP3
SCHEMBL2733167 0.72 HTR6 (0.40) ACLYHTR6PSEN1PSEN2APH1B
SCHEMBL2733056 0.70 HTR6 (0.42) ACLYHTR6PSEN1PSEN2APH1B
SCHEMBL2732065 0.70 HTR6 (0.42) ACLYHTR6PSEN1PSEN2APH1B
SCHEMBL28019783 0.68 AGTR1 (0.47) ACLYAGTR1HTR6FABP3FABP4
SCHEMBL4119321 0.65 ACLY (0.51) ACLYAGTR1HTR6FABP3FABP4
SCHEMBL2732076 0.65 FABP3 (0.50) ACLYAGTR1HTR6FABP3FABP4
SCHEMBL6829775 0.65 AKR1C3 (0.48) ACLYAGTR1HTR6FABP3FABP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012059568-A1 NOVEL WATER-SOLUBLE INDOLOBENZAZEPINE MOLECULES DEMONSTRATING ANTIMITOTIC, ANTIVASCULAR, AND ANTITUMOR ACTIVITIES IN VIVO CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) 2012-05-10 WO disclosed